OraGen Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
OraGen General Information
Description
Developer of immune regulation technologies located in Morristown, NJ. The company specializes in methods and compositions that would be useful for regulating undesirable immune responses exhibited by individuals with infectious diseases.
Contact Information
Corporate Office
- Morristown, NJ
- United States
Corporate Office
- Morristown, NJ
- United States
OraGen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
OraGen Patents
OraGen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2004035007-A2 | Transmucosal administration of aggregated antigens | Inactive | 17-Oct-2002 | ||
| WO-2004035007-A3 | Transmucosal administration of aggregated antigens | Inactive | 17-Oct-2002 |
OraGen Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
OraGen FAQs
-
Where is OraGen headquartered?
OraGen is headquartered in Morristown, NJ.
-
What industry is OraGen in?
OraGen’s primary industry is Biotechnology.
-
Is OraGen a private or public company?
OraGen is a Private company.
-
What is OraGen’s current revenue?
The current revenue for OraGen is .
-
Who are OraGen’s investors?
Autoimmune has invested in OraGen.
-
When was OraGen acquired?
OraGen was acquired on 26-Feb-2004.
-
Who acquired OraGen?
OraGen was acquired by Enzo Biochem.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process